Full Text View
Tabular View
No Study Results Posted
Related Studies
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study (MAPS)
This study is currently recruiting participants.
Study NCT00651456   Information provided by Intergroupe Francophone de Cancerologie Thoracique
First Received: March 29, 2008   Last Updated: August 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mesothelioma
More general conditions related to this trial
Adenoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Additional drug interventions recognized in this trial
Bevacizumab
Cisplatin
Pemetrexed
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Growth Inhibitors
Growth Substances
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Intergroupe Francophone de Cancerologie Thoracique
University Hospital, Caen
Groupe Francais de Pneumo-Cancérologie
European Lung Cancer Working Party


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services